Alcohol and Race/Ethnicity Elicit Different Changes in Lipid Profiles in HIV-Infected Individuals Receiving Highly Active Antiretroviral Therapy

Journal of the Association of Nurses in AIDS Care

Volumn 20, Issue 3, 2009, Pages 176-183

  Míguez Burbano, Maria J ^a   Lewis, John E ^a   Malow, Robert ^a  

^a NONE

Author keywords

alcohol; antiretrovirals; cardiovascular disease; triglycerides

Indexed keywords

LIPID;

ADULT; ARTICLE; BLOOD; DRINKING BEHAVIOR; ETHNIC GROUP; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; RACE;

ADULT; ALCOHOL DRINKING; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HUMANS; LIPIDS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

EID: 65449188336     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2009.02.004     Document Type: Article

References (24)

1. Albu J.B., Murphy L., Frager D.H., Johnson J.A., and Pi-Sunyer F.X. Visceral fat and race-dependent health risks in obese non-diabetic premenopausal women. Diabetes 46 (1997) 456-462
2. Bausserman L.L., Tashima K.T., DiSpigno M., Maceroni D., and Carpenter C.C. Racial differences in serum lipids in HIV+ women treated with protease inhibitor regimens. HIV Clinical Trials 5 (2004) 399-405
3. Bozkurt B. Cardiovascular toxicity with highly active antiretroviral therapy: Review of clinical studies. Cardiovascular Toxicology 4 (2004) 243-260
4. Calza R., Manfredi R., and Chiodo F. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. Journal of Antimicrobial Chemotherapy 53 (2004) 10-14
5. Carr A., Samaras K., Burton S., Law M., Freund J., Chisholm A., et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12 (1998) F51
6. de Jong, H J.I., de Goede J., Griep L.M.O., and Geleijnse J.M. Alcohol consumption and blood lipids in elderly coronary patients. Metabolism: Clinical and Experimental 57 (2008) 1286-1292
7. Després J.P., Couillard C., Gagnon J., Bergeron J., Leon A.S., Rao D.C., et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: The Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study. Arteriosclerosis, Thrombosis, and Vascular Biology 20 (2000) 1932-1938
8. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association 285 (2001) 2486-2497
9. Fauvel J., Bonnet E., Ruidavets J.B., Ferrieres J.B., Toffoletti A., Massipet P.A., et al. An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients. AIDS 15 (2001) 2397-2406
10. Foulkes A.S., Whol D.A., Franl I., Puleo E., Restine S., Megan L., et al. Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. PLoS Med 3 (2006) e52
11. Freudenheim J.L., Ram M., Nie J., Muti P., Trevisan M., Shields P.G., et al. Lung cancer in humans is not associated with lifetime total alcohol consumption or with genetic variation in alcohol dehydrogenase 3 (ADH3). Journal of Nutrition 133 (2003) 3619-3624
12. Friis-Moller N., Reiss P., Sabin C.A., Weber R., Monfort d., El-Sadr W., et al. Class of antiretroviral drugs and the risk of myocardial infarction. New England Journal of Medicine 356 (2007) 1723-1735
13. Gerber J.G., Rosenkranz S.L., Fichtenbaum C.J., Vega J.M., Yang A., Alston B.L., et al. Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: Results of AIDS Clinical Trials Group 5108 Study. Clinical Trial, Phase I. Multicenter Study. Journal of Acquired Immune Deficiency Syndromes 39 (2005) 307-312
14. Gkrania-Klotsas E., and Klotsas A.-E. HIV and HIV treatment: Effects on fats, glucose and lipids. British Medical Bulletin 84 (2007) 49-68
15. Lovejoy J.C., de la Bretonne J.A., Klemperer M., and Tulley R. Abdominal fat distribution and metabolic risk factors: Effects of race. Metabolism 45 (1996) 1119-1124
16. Míguez M.J., Shor-Posner G., Morales G., Rodriguez A., and Burbano X. HIV treatment in drug abusers: Impact of alcohol use. Addiction Biology 8 (2003) 33-37
17. Miguez-Burbano M.J., Lewis J.E., Moreno J., and Fishman J. Cognitive performance and the thymus among HIV-infected subjects receiving HAART. Journal of Biologics: Targets and Therapy 2 (2008) 321-327
18. Miller K.D., Jones E., Yanovski J.A., Shankar R., Feuerstein I., and Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351 (1998) 871
19. Montes M.L., Pulido F., Barros C., Condes E., Rubio R., Cepeda C., et al. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: Frequency, characterization and risk factors. Journal of Antimicrobial Chemotherapy 55 (2005) 800-804
20. National Institute on Alcohol Abuse and Alcoholism (1995). The physician's guide to helping patients with alcohol problems. Washington, DC: National Institutes of Health. NIH publication 95-3769.
21. Olshan A.F., Weissler M.C., Watson M.A., and Bell D.A. Risk of head and neck cancer and the alcohol dehydrogenase 3 genotype. Carcinogenesis 22 (2001) 57-61
22. Panel on Antiretroviral Guidelines for Adults and Adolescents. (2008). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Retrieved February 15, 2009, from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
23. Schmidt M.I., Duncan B.B., Watson R.L., Sharrett A.R., Brancati F.L., and Heiss G. A metabolic syndrome in whites and African-Americans: The Atherosclerosis Risk in Communities Baseline Study. Diabetes Care 19 (1996) 414-418
24. Viraben R., and Aquilina C. Indinavir-associated lipodystrophy. AIDS 12 (1998) F37